Search Results 891-900 of 9160 for Conduction

  1. Steven W. Ressler, M.D. - Mayo Clinic Faculty Profiles

    The research of Steven W. Ressler, M.D., a Mayo Clinic internist, focuses on the early stages of the cancer care continuum, including early cancer ...

  2. Mayo Clinic

    ... . IMG-20076720. Home; SM00055Deepwaterwalkingwithhandwebs. 5X Challenge is here! 5X My Gift! Your gift today can have 5X the impact on AI research and ...

  3. Neurology - Clinical trials

    The purpose of this study is to evaluate the effectiveness of ONC201 administered following radiotherapy in participants with H3 K27M-mutant diffuse glioma. A ...

  4. Publications - Frederick Chen, M.D. - Mayo Clinic

    Lu PG, Hangge PT, Mathur AK, Wasif N, Ven Fong Z, Cronin PA, Adler C, Chen F, Stucky CH. Management of Incidental Thyroid Nodules in the Pretransplant ...

  5. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    ... conduction defect with a QRS duration ≥ 150 msec or evidence of acute or sub-acute myocardial infarction or ischemia or other ECG findings that, in the ...

  6. Publications - Onur Demirci, M.D. - Mayo Clinic

    Panchamia JK, Amundson AW, Demirci O, Braksick SA, Wijdicks EF. A Case Report of "Propofol Frenzy": Anesthetic Considerations for a Severe Propofol-Induced ...

  7. Neurology - Clinical trials

    The purpose of this study is to evaluate plasma biomarkers of vascular function and inflammation in patients with newly-diagnosed Obstructive Sleep Apnea (OSA) ...

  8. RAPA-501 Therapy for ALS Expanded Access Protocol - Mayo Clinic

    ... conduction system abnormalities. HIV, hepatitis B, or hepatitis C seropositive. Pregnant or breastfeeding subjects. Subjects of childbearing age, or males ...

  9. Gastroenterology and Hepatology - Clinical trials

    Other enteropathies will also be included: collagenous sprue, idiopathic sprue, lymphocytic enterocolitis, idiopathic enteropathies, collagenous gastritis, ...

  10. Clinical trials - Oncology (Medical)

    Also, to establish for future clinical development the recommended Phase 2 dose (RP2D) of Q901 monotherapy when administered via IV infusion QW for 4 weeks and ...